Novartis picks Precision Bio to bring in vivo gene editing meds to blood disorders
8 days ago - By MedCity News
Novartis is paying Precision Bio $75 million up front to begin a partnership aiming to develop in vivo gene-editing therapies for serious genetic blood disorders, such as sickle cell disease. One of the goals of the alliance is to make genetic medicines more globally accessible.
Read more ...
The headlines of Care Mag
Social Drivers of Cancer Mortality: Part 2
Measuring and addressing social drivers of health are important in cancer research. Part 1 of this series, published in March 2022 , described three commonly used area-level...
Why High-Profile Convictions Are So Traumatizing For Victims Of Sexual Abuse
R. Kelly's sentencing may cause sexual abuse survivors to reflect on the punishment their abuser received ― or didn't receive.
A Bet She Couldn't Resist
For $100, could I stop flirting with men when my mother was around? And could she stop talking about my brush with mortality?
Your Guide To The Absolute Best Low-Carb Meal Delivery Services
Step away from the stove.
We All Need A Mood Lift These Days - This Essential Vitamin Can Help
When our outer world feels chaotic, our inner worlds need some TLC.
How to Dispute Surprise Medical Bills
After receiving a $21,500 doctor's bill for a mere 10 stitches, I researched bad medical billing. Here's how to fight it.
7 Simple & Healthy Morning Habits To Start Your Day Off On The Right Foot
Because every morning should be a good morning.
‘It's not going to work': Keeping race out of machine learning isn't enough...
‘It's not going to work': Keeping race out of machine learning isn't enough to avoid bias NIBIB in the News kolsen Thu, 06/30/2022 - 15:27 As more machine learning tools reach...
Prone to Body Acne? This $28 Moisture Gel Cream Is Like Gatorade for Your Skin
If you purchase an independently reviewed product or service through a link on our website, STYLECASTER may receive an affiliate commission. For those of us who are acne-prone...
This Moisturizer Works Better Than Luxury Formulas
It's quite the steal.